Kevin King

Partner

+1 202 842 7823
kking@cooley.com

Kevin King concentrates his practice in the areas of export regulation, US and multilateral economic sanctions, Foreign Corrupt Practices Act (FCPA) compliance and corporate internal investigations.

Download full bio

Experience

  • Crown Bioscience Enters Merger Agreement With JSR Corporation 

  • Atlassian - $531 Million IPO 

  • SolidFire sale to NetApp 

  • Aclaris Therapeutics IPO 

  • Dot Hill Systems sale to Seagate Technology 

  • View all

Education

  • Stanford Law School
    JD, 1997

  • American University
    BA, magna cum laude, 1992


Admissions & Credentials

District of Columbia

Contact

+1 202 842 7823 office
+1 202 842 7899 fax
kking@cooley.com

1299 Pennsylvania Avenue, NW
Suite 700
Washington, DC 20004-2400